Asthma Clinical Pathway — Inpatient
Asthma Control Assessment
Patient < 5 years Is this their second asthma exacerbation requiring systemic steroids in 6 months? |
Patient ≥ 5 years Is this their second exacerbation requiring systemic steroids in 12 months? |
---|---|
If yes, asthma is not well controlled, consider Step up (see Stepwise table below). If no, assess asthma control based on symptoms/impairment prior to onset of this exacerbation. Assess control using Asthma Control Tool Recommend Step up at discharge if not well or poorly controlled. |
Stepwise Recommended Medication Escalation Treatment for Managing Asthma Long Term
Adapted from 2020 Focused Updates to the Asthma Management Guidelines: Clinician's Guide
Age, years | Step 1 | Step 2 | Step 3 | Step 4 | Step 5† | Step 6† |
---|---|---|---|---|---|---|
Symptoms | Intermittent | Mild Persistent | Moderate Persistent | Severe Persistent | ||
0-4** Preferred |
SABA as needed for symptoms And at the start of RTI add short course of daily ICS when Asthma Predictive Index (API) is positive |
Low-dose ICS and PRN SABA | Medium dose ICS and PRN SABA. | Daily medium-dose ICS-LABA and PRN SABA | Daily high-dose ICS-LABA and PRN SABA | Daily high-dose ICS-LABA + OCS and PRN SABA |
5-11 Preferred | SABA as needed for symptoms | Daily Low-dose ICS and PRN SABA | Daily and PRN combination low-dose ICS-formoterol | Daily and PRN medium-dose ICS-formoterol | Daily high-dose ICS-LABA and PRN SABA | Daily high-dose ICS-LABA + OCS and PRN SABA |
≥ 12 Preferred | SABA as needed for symptoms | Daily Low-Dose ICS and PRN SABA or PRN concomitant ICS and SABA | Daily and PRN combination low-dose ICS-formoterol | Daily and PRN combination medium-dose ICS-formoterol | Daily medium or high-dose ICS-LABA + LAMA and PRN SABA | Daily high-dose ICS-LABA + OCS + PRNs SABA |
Quick Relief |
Use SABA as needed for symptoms. The intensity of treatment depends on the severity of symptoms: up to 3 treatments at 20-minute intervals as needed. *In steps 3 and 4, the preferred option includes the use of ICS-formoterol 1 to 2 puffs as needed up to a maximum total daily maintenance and rescue dose of 8 puffs (< 12 years) and 12 puffs (> 12 years). |
|||||
*Preferred **Adapted from 2020 NHLBI Asthma Focused Updates Highlighted table cells are consistent with SMART |
API, Preschool Age
Early frequent wheezer (≥ 3x) and 1 major or 2 minor
Major Criteria |
|
---|---|
Minor Criteria |
|
Inhaled Corticosteroids (ICS)
Therapeutic Substitution of Inhaled Corticosteroids
Note: Dose recommendations for each brand of product are based on data from that product’s labeling. Though equivalent doses have not been established, the following dose substitution charts for HFA Metered Dose Inhalers, a Breath-Actuated Inhaler, and Dry Powder Inhalers can be utilized for therapeutic substitution. Patient-specific responses to different products within these two categories of inhalers may vary so patients should be closely monitored for dose effectiveness.
Caution: DPI and HFA formulations are NOT interchangeable
< 12 years, Breath-Actuated and HFA inhalers
Breath-Actuated Metered Dose Inhaler | ||||||
---|---|---|---|---|---|---|
Beclomethasone(QVAR RediHaler) | Fluticasone HFA (Flovent HFA) | Mometasone HFA (Asmanex HFA) | ||||
Inhaler strength | Regimen | Inhaler strength | Regimen | Inhaler strength | Regimen | |
LOW Daily Dose |
40 mcg/inhalation | 1 inhalation BID | 44 mcg/puff | 1 puff BID | 100 mcg/puff | 1 puff at night |
40 mcg/inhalation | 2 inhalations BID | 44 mcg/puff | 2 puffs BID | 100 mcg/puff | 1 puff at night | |
MEDIUM Daily Dose |
80 mcg/inhalation | 2 inhalations BID | 110 mcg/puff | 1 puff BID | 100 mcg/puff | 1 puff BID |
HIGH Daily Dose |
80 mcg/inhalation | 3 inhalations BID | 220 mcg/puff | 1 puff BID | 200 mcg/puff | 1 puff BID |
80 mcg/inhalation | 4 inhalations BID | 220 mcg/puff | 2 puffs BID | 200 mcg/puff | 2 puffs BID |
< 12 years, Dry Powder Inhalers
Dry Powder Inhaler (DPI) | ||||||
---|---|---|---|---|---|---|
Budesonide (Pulmicort Flexhaler) |
Fluticasone Diskus (Flovent Diskus) |
Mometasone DPI (Asmanex Twisthaler) |
||||
Inhaler strength | Regimen | Inhaler strength | Regimen | Inhaler strength | Regimen | |
LOW Daily Dose |
90 mcg/puff | 1 puff BID | 50 mcg/puff | 1 puff BID | 110 mcg/puff | 1 puff at night |
90 mcg/puff | 2 puffs BID | 50 mcg/puff | 2 puffs BID | 110 mcg/puff | 1 puff at night | |
MEDIUM Daily Dose |
180 mcg/puff | 2 puffs BID | 100 mcg/puff | 2 puffs BID | 110 mcg/puff | 1 puff BID |
HIGH Daily Dose |
180 mcg/puff | 3 puffs BID | 250 mcg/puff | 1 puff BID | 220 mcg/puff | 1 puff BID |
180 mcg/puff | 4 puffs BID | 250 mcg/puff | 2 puffs BID | 220 mcg/puff | 2 puffs BID |
≥ 12 years, Breath-Actuated
Breath-Actuated Metered Dose Inhaler | ||||||
---|---|---|---|---|---|---|
Beclomethasone (QVAR RediHaler) |
Fluticasone HFA (Flovent HFA) |
Mometasone HFA (Asmanex HFA) |
||||
Inhaler strength | Regimen | Inhaler strength | Regimen | Inhaler strength | Regimen | |
LOW Daily Dose |
40 mcg/inhalation | 1 inhalation BID | 44 mcg/puff | 1 puff BID | 100 mcg/puff | 1 puff at night |
40 mcg/inhalation | 2 inhalations BID | 44 mcg/puff | 2 puffs BID | 100 mcg/puff | 2 puffs at night | |
80 mcg/inhalation | 1 inhalation BID | 110 mcg/puff | 1 puff BID | 100 mcg/puff | 1 puff BID | |
MEDIUM Daily Dose |
80 mcg/inhalation | 2 inhalations BID | 110 mcg/puff | 2 puffs BID | 100 mcg/puff | 2 puffs BID |
80 mcg/inhalation | 3 inhalations BID | 220 mcg/puff | 1 puff BID | 200 mcg/puff | 1 puff BID | |
HIGH Daily Dose |
80 mcg/inhalation | 4 inhalations BID | 220 mcg/puff | 2 puffs BID | 200 mcg/puff | 2 puffs BID |
≥ 12 years, Dry Powder Inhalers
Dry Powder Inhaler (DPI) | ||||||
---|---|---|---|---|---|---|
Budesonide (Pulmicort Flexhaler) |
Fluticasone Diskus (Flovent Diskus) |
Mometasone DPI (Asmanex Twisthaler) |
||||
Inhaler strength | Regimen | Inhaler strength | Regimen | Inhaler strength | Regimen | |
LOW Daily Dose |
90 mcg/puff | 1 puff BID | 50 mcg/puff | 1 puff BID | 110 mcg/puff | 1 puff at night |
90 mcg/puff | 2 puffs BID | 50 mcg/puff | 2 puffs BID | 110 mcg/puff | 2 puffs at night | |
180 mcg/puff | 1 puff BID | 100 mcg/puff | 2 puffs BID | 110 mcg/puff | 1 puff at night | |
MEDIUM Daily Dose |
180 mcg/puff | 2 puffs BID | 100 mcg/puff | 2 puffs BID | 110 mcg/puff | 1 puff BID |
180 mcg/puff | 3 puffs BID | 250 mcg/puff | 1 puff BID | 220 mcg/puff | 1 puff BID | |
HIGH Daily Dose |
180 mcg/puff | 4 puffs BID | 250 mcg/puff | 2 puffs BID | 220 mcg/puff | 2 puffs BID |
HFA Inhalers
Breath-Actuated Metered Dose Inhaler | ||||||
---|---|---|---|---|---|---|
Budesonide/formoterol HFA (Symbicort HFA) |
Mometasone/formoterol HFA (Dulera HFA) |
Fluticasone/salmeterol HFA (Advair HFA) |
||||
Inhaler strength | Regimen | Inhaler strength | Regimen | Inhaler strength | Regimen | |
LOW Daily Dose |
80 mcg/4.5 mcg per puff | 2 puffs BID | 100 mcg/5 mcg per puff | 2 puffs daily | 45 mcg/21 mcg per puff | 2 puffs BID |
MEDIUM Daily Dose |
160 mcg/4.5 mcg per puff | 2 puffs BID | 100 mcg/5 mcg per puff | 2 puffs BID | 115 mcg/21 mcg per puff | 2 puffs BID |
HIGH Daily Dose |
Not applicable (only low or medium dose options) | 200 mcg/5 mcg per puff | 2 puffs BID | 230 mcg/21 mcg per puff | 2 puffs BID |
Dry Powder Inhalers
Dry Powder Inhaler (DPI) | ||||
---|---|---|---|---|
Fluticasone/salmeterol | ||||
Advair Diskus | AirDuo RespiClick/Generic RespiClick | |||
Inhaler strength | Regimen | Inhaler strength | Regimen | |
LOW Daily Dose |
100 mcg/50 mcg per inhalation | 1 inhalation BID | 55 mcg/14 mcg per inhalation | 1 inhalation BID |
MEDIUM Daily Dose |
250 mcg/50 mcg per inhalation | 1 inhalation BID | 113 mcg/14 mcg per inhalation | 1 inhalation BID |
HIGH Daily Dose |
500 mcg/50 mcg per inhalation | 1 inhalation BID | 232 mcg/14 mcg per inhalation | 1 inhalation BID |